CCA
MACK

Catalyst Capital Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Catalyst Capital Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-8,236
Closed -$569K – 580
2014
Q3 		$569K Buy
8,236
+4,448
+117% +$307K 0.07% 224
2014
Q2 		$217K Sell
3,788
-44,624
-92% -$2.56M 0.04% 275
2014
Q1 		$1.92M Buy
48,412
+6,355
+15% +$252K 0.43% 88
2013
Q4 		$1.77M Buy
+42,057
New +$1.77M 0.57% 68